Pelvic Floor Myofascial Pain Syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Female, aged 18 to 65 years; 2. Clinically diagnosed with Pelvic Floor Myofascial Pain Syndrome (PFMPS) according to the following diagnostic criteria: A. Myofascial trigger points (MTrPs) identified through pelvic floor muscle palpation, standardized vaginal examination by an experienced clinician; B. Pelvic floor muscle tenderness and/or tension/spasm detected; C. Exclusion of other obvious organic or neurological causes of pain; 3. Clean lochia with no active vaginal bleeding; 4. Willing to voluntarily sign informed consent and comply with treatment and follow-up.
Exclusion criteria
Exclusion criteria: 1. Active pelvic infections (such as vaginitis, cervicitis, pelvic inflammatory disease, etc.); 2. History or suspicion of pelvic or urogenital malignancy; 3. Pregnancy or plans to become pregnant during the study period; 4. Pelvic pain caused by other uncontrolled diseases (such as active endometriosis); 5. Presence of pelvic implants or other contraindications for electrical stimulation or microwave therapy (e.g., pacemakers); 6. Severe mental or cognitive disorders that significantly affect adherence to the study or outcome evaluation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MTrPs-triggered pain Visual Analog Scale (VAS);Number of MTrPs;Surface Electromyography (sEMG) Glazer Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Oxford Muscle Strength Score (0-5 points);Pelvic Floor Distress Inventory (PFDI-20);Pelvic Floor Impact Questionnaire (PFIQ-7);Female Sexual Function Index (FSFI);Patient Global Impression of Improvement (PGI-I); | — |
Countries
China
Contacts
Jiaxing University Affiliated Women and Children Hospital